共 542 条
[1]
Wu Z(2020)Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in china: summary of a report of 72314 cases from the Chinese center for disease control and prevention JAMA 323 1239-1242
[2]
McGoogan JM(2020)Variation in US Hospital mortality rates for patients admitted with COVID-19 during the first 6 months of the pandemic JAMA Intern Med 384 693-704
[3]
Asch DA(2020)Long term outcomes of critically ill COVID-19 pneumonia patients: early learning Intensive Care Med 202 1460-1462
[4]
Sheils NE(2021)Dexamethasone in hospitalized patients with Covid-19 N Engl J Med 2 e594-e602
[5]
Islam MN(2020)Immunomodulators in COVID-19: two sides to every coin Am J Respir Crit Care Med 202 812-821
[6]
Chen Y(2020)COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study Lancet Rheumatol 8 1233-1244
[7]
Werner RM(2020)Characterization of the inflammatory response to severe COVID-19 illness Am J Respir Crit Care Med 339 b2700-926
[8]
Buresh J(2020)Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes Lancet Respir Med 366 l4898-3457
[9]
Doshi JA(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 336 924-468
[10]
McCue C(2019)RoB 2: a revised tool for assessing risk of bias in randomised trials BMJ 25 3443-40